Funded Tech Companies
Satori Pharmaceuticals
Wondering who invested in Satori Pharmaceuticals? New Enterprise Associates, InterWest Partners and private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Satori Pharmaceuticals
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
281 Albany Street
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/23/2012
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Ives
VP - R & D
Brian Bronk
VP - R & D
Barbara Tate
Company Investors
- New Enterprise Associates (Ed Mathers)
- InterWest Partners (Christopher Ehrlich)
- Prospect Venture Partners (David Schnell)
- PureTech Ventures (Benjamin Shapiro)
- Prospect Venture Partners (Ilan Zipkin)
- PureTech Ventures (Daphne Zohar)
- Polaris Partners
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs